We observed that the accumulation of macrophages in tumors could be reduced by selectively targeting the GPER1 signaling with G-1 in mouse models of HCC, suggesting a potential strategy to modulate the macrophage pool by targeting estrogen receptor signaling. Here, ESR1 is linked to hepatocellular carcinoma.